Metropolis Healthcare Q1FY27 revenue up about 16% year-on-year

Metropolis Healthcare shared its Q1FY27 business update. Consolidated revenue grew about 16% year-on-year, driven mainly by patient volumes and better realisation from a product mix change. TruHealth Wellness and Specialty were the fastest growing segments. B2C volumes rose from the expanded centre network, while B2B grew on higher wallet share and new customer wins. EBITDA margins improved year-on-year in line with earlier guidance and were largely stable sequentially. Detailed Q1 financials are pending Board approval and auditor review.